MedTrace Logo

A Randomized, Multicenter, Study for the prEvention and Acute Treatment of Migraine (REAL)

NCT03787238 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-06-14

No results posted yet for this study

Summary

This is a randomized study for the prevention and acute treatment of migraine using open label nVNS and standard of care versus standard of care.

.

Conditions

Interventions

DEVICE

non-invasive vagus nerve stimulation

non-invasive vagus nerve stimulation using the gammaCore Sapphire device

Sponsors & Collaborators

  • ElectroCore INC

    lead INDUSTRY

Principal Investigators

  • Alexandra Sinclair, MD · University of Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-15
Primary Completion
2020-09-01
Completion
2020-10-01
FDA Device
Yes

Countries

  • Denmark
  • Germany
  • Italy
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03787238 on ClinicalTrials.gov